Correlation Between Medigen Biotechnology and OBI Pharma
Can any of the company-specific risk be diversified away by investing in both Medigen Biotechnology and OBI Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medigen Biotechnology and OBI Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medigen Biotechnology and OBI Pharma, you can compare the effects of market volatilities on Medigen Biotechnology and OBI Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medigen Biotechnology with a short position of OBI Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medigen Biotechnology and OBI Pharma.
Diversification Opportunities for Medigen Biotechnology and OBI Pharma
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Medigen and OBI is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Medigen Biotechnology and OBI Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OBI Pharma and Medigen Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medigen Biotechnology are associated (or correlated) with OBI Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OBI Pharma has no effect on the direction of Medigen Biotechnology i.e., Medigen Biotechnology and OBI Pharma go up and down completely randomly.
Pair Corralation between Medigen Biotechnology and OBI Pharma
Assuming the 90 days trading horizon Medigen Biotechnology is expected to under-perform the OBI Pharma. In addition to that, Medigen Biotechnology is 1.03 times more volatile than OBI Pharma. It trades about -0.13 of its total potential returns per unit of risk. OBI Pharma is currently generating about -0.13 per unit of volatility. If you would invest 6,520 in OBI Pharma on August 29, 2024 and sell it today you would lose (230.00) from holding OBI Pharma or give up 3.53% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Medigen Biotechnology vs. OBI Pharma
Performance |
| Timeline |
| Medigen Biotechnology |
| OBI Pharma |
Medigen Biotechnology and OBI Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Medigen Biotechnology and OBI Pharma
The main advantage of trading using opposite Medigen Biotechnology and OBI Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medigen Biotechnology position performs unexpectedly, OBI Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OBI Pharma will offset losses from the drop in OBI Pharma's long position.The idea behind Medigen Biotechnology and OBI Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| OBI Pharma vs. TaiMed Biologics | OBI Pharma vs. PharmaEngine | OBI Pharma vs. Medigen Biotechnology | OBI Pharma vs. TTY Biopharm Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |